SILK RD MED INC's ticker is SILK and the CUSIP is 82710M100. A total of 158 filers reported holding SILK RD MED INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,162,643 | -25.2% | 80,824 | +1.0% | 0.00% | 0.0% |
Q4 2022 | $4,228,000 | +246.3% | 80,014 | +194.8% | 0.00% | – |
Q3 2022 | $1,221,000 | +5.9% | 27,140 | -14.3% | 0.00% | – |
Q2 2022 | $1,153,000 | +3.4% | 31,677 | +17.4% | 0.00% | – |
Q1 2022 | $1,115,000 | -94.9% | 26,992 | -94.8% | 0.00% | -100.0% |
Q4 2021 | $22,063,000 | -33.8% | 517,827 | -14.5% | 0.01% | -45.5% |
Q3 2021 | $33,318,000 | +15.1% | 605,499 | +0.1% | 0.01% | +22.2% |
Q2 2021 | $28,939,000 | -7.2% | 604,638 | -1.8% | 0.01% | -10.0% |
Q1 2021 | $31,182,000 | +40.2% | 615,676 | +74.3% | 0.01% | +25.0% |
Q4 2020 | $22,248,000 | +26.2% | 353,300 | +34.7% | 0.01% | +14.3% |
Q3 2020 | $17,625,000 | +22.8% | 262,226 | -24.1% | 0.01% | +16.7% |
Q2 2020 | $14,354,000 | +1974.3% | 345,534 | +1471.3% | 0.01% | – |
Q1 2020 | $692,000 | +1.9% | 21,990 | +30.8% | 0.00% | – |
Q4 2019 | $679,000 | +36.6% | 16,810 | +9.9% | 0.00% | – |
Q3 2019 | $497,000 | -32.6% | 15,290 | +0.6% | 0.00% | – |
Q2 2019 | $737,000 | – | 15,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SECTORAL ASSET MANAGEMENT INC | 399,483 | $25,159,000 | 1.77% |
NEXT CENTURY GROWTH INVESTORS LLC | 313,534 | $19,746,000 | 1.66% |
Graticule Asia Macro Advisors LLC | 52,565 | $3,311,000 | 1.59% |
Bullseye Asset Management LLC | 58,112 | $3,659,000 | 1.36% |
EMC Capital Management | 24,598 | $1,549,000 | 1.18% |
Parkman Healthcare Partners LLC | 67,854 | $4,273,000 | 1.10% |
Nicholas Investment Partners, LP | 219,483 | $13,823,000 | 1.07% |
SCHOLTZ & COMPANY, LLC | 37,517 | $2,363,000 | 0.92% |
WASATCH ADVISORS LP | 2,630,013 | $165,638,000 | 0.82% |
Rhenman & Partners Asset Management AB | 125,000 | $7,873,000 | 0.64% |